Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts

被引:115
作者
Zhang, Hong [1 ]
Xing, Wei-Wei [1 ,2 ]
Li, Yu-Shan [2 ]
Zhu, Zheng [2 ,3 ]
Wu, Jin-Zhong [4 ]
Zhang, Qiao-Yan [1 ]
Zhang, Wen [1 ]
Qin, Lu-Ping [1 ]
机构
[1] Second Mil Med Univ, Dept Pharmacognosy, Sch Pharm, Shanghai 200433, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Dept Pharmacognosy, Shenyang 110016, Peoples R China
[3] China Med Univ, Sch Pharmaceut Sci, Shenyang 110001, Peoples R China
[4] Fujian Coll Tradit Chinese Med, Acad Integrat Med, Fuzhou 350108, Fujian, Peoples R China
关键词
Er-Zhi-Wan; Traditional Chinese formulation; Osteoporosis; Serum pharmacology;
D O I
10.1016/j.maturitas.2008.09.023
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
Background: Bone formation and resorption is a balanced and continuous process. When osteoclastic bone resorption exceeds osteoblastic bone formation, bone density decreases, which can lead to osteoporosis. Er-Zhi-Wan (EZW), a famous traditional Chinese formulation, has been developed as a restorative formula for hundreds of years, which contains two herbs viz. Herba Ecliptae and Fructus Ligustri Lucidi. EZW is widely used to prevent and treat various kidney diseases for its actions of nourishing the kidney yin and strengthening tendon and bone. The objective of current study was to investigate the effects of EZW on proliferation and differentiation of osteoblasts and osteoclasts in vitro using a serum pharmacological method. Methods: The rats were orally administered EZW (0.45. 1.8 and 7.2 gkg(-1)) for total seven doses and twice a day, and then the different concentrations of EZW-containing serum were prepared. The proliferation of primary cultural osteoblasts, UMR706 and RAW264.7 cells and differentiation of osteoclasts were determined after these cells were treated with different concentrations of EZW-containing serum for a period of time. Results: The serum from rats treated with EZW for 4 days did not facilitate proliferation of primary cultural osteoblasts and UMR 106 cells, but evidently inhibited both proliferation of RAW264.7 cells and differentiation of osteoclasts from RAW264.7 cells induced by receptor activator of nuclear factor kappa B ligand (RANK-L) and macrophage-colony stimulating factor (M-CSF). Conclusion: Antiosteoporotic activity of EZW is carried out mainly via restraint of osteoclastic bone resorption, which is in accordance with the traditional Chinese medicine theory on nourishing the kidney yin. Therefore EZW has favorable potency to develop a new anti-osteoporotic agent in clinic. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:334 / 339
页数:6
相关论文
共 38 条
[1]
BENNET AE, 1984, J ENDOCRINOL, V102, P49
[2]
CAI J, 2006, J FUJIAN COLL TCM, V16, P34
[3]
Canalis H, 1998, J CLIN INVEST, V81, P277
[4]
Androgen disruption and toxicity tests of Butea superba Roxb., a traditional herb used for treatment of erectile dysfunction, in male rats [J].
Cherdshewasart, Wichai ;
Bhuntaku, Papong ;
Panriansaen, Rattana ;
Dahlan, Winai ;
Malaivijitnond, Suchinda .
MATURITAS, 2008, 60 (02) :131-137
[5]
FROST HM, 1992, J BONE MINER RES, V7, P253
[6]
The human osteoclast precursor circulates in the monocyte fraction [J].
Fujikawa, Y ;
Quinn, JMW ;
Sabokbar, A ;
McGee, JO ;
Athanasou, NA .
ENDOCRINOLOGY, 1996, 137 (09) :4058-4060
[7]
ESTROGENS IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN [J].
GENANT, HK ;
BAYLINK, DJ ;
GALLAGHER, JC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) :1842-1846
[8]
ACID PHOSPHATASE ACTIVITY IN HUMAN BLOOD CELLS [J].
GOLDBERG, AF ;
BARKA, T .
NATURE, 1962, 195 (4838) :297-&
[9]
Potential function for the ROS-generating activity of TRACP [J].
Halleen, JM ;
Räisänen, SR ;
Alatalo, SL ;
Väänänen, HK .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (10) :1908-1911
[10]
Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase [J].
Halleen, JM ;
Räisänen, S ;
Salo, JJ ;
Reddy, SV ;
Roodman, GD ;
Hentunen, TA ;
Lehenkari, PP ;
Kaija, H ;
Vihko, P ;
Väänänen, HK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :22907-22910